Sex: F
Vaccine: COVID19
Symptoms: Angina pectoris, Inappropriate schedule of product administration
Clinical narrative: heart pain/chest, 2nd shot: more pain; 1st shot 27Jun2021, 2nd shot 06Aug2021; This is a spontaneous report received from a Consumer or other non HCP.  An elderly female patient received BNT162b2 (BNT162B2), on 06Aug2021 as dose 2, single (Lot number: FA7485), in arm for covid-19 immunisation. The patient's relevant medical history included: "latex allergy" (unspecified if ongoing); "latex allergy-rash" (unspecified if ongoing); "allergy shellfish, nuts (walnuts)" (unspecified if ongoing); "allergies to hot and cold weather changes" (unspecified if ongoing); "allergy-trouble breathing" (unspecified if ongoing); "mast cell activation syndrome, unspecified", start date: 2019 (unspecified if ongoing); "dermographism", start date: 2018 (unspecified if ongoing); "esophageal dysmotility/hypotensive LES", start date: 2018 (unspecified if ongoing); "absent esophageal peristalsis" (unspecified if ongoing); "hiatal hernia" (unspecified if ongoing); "vocal cord dysfunction", start date: 2018 (unspecified if ongoing); "IBS-C", start date: 2018 (unspecified if ongoing); "acid reflux/GERD" (unspecified if ongoing); "osteoporosis" (unspecified if ongoing); "fibromyalgia" (unspecified if ongoing); "diced food diet/FODMAP and Histamine diets", start date: 2015 (unspecified if ongoing), notes: loss of muscle strength during a swallow study, swallowing exercises; "loss of muscle strength", start date: 2015 (unspecified if ongoing), notes: during a swallow study, swallowing exercises; "Chronic fatigue syndrome" (unspecified if ongoing), notes: start dates: 1980s; "Epstein Barr Virus" (unspecified if ongoing), notes: start dates: 1980s; "mild sleep apnea" (unspecified if ongoing); "oral lichen planus" (unspecified if ongoing), notes: start date: 1990s; "surgery for squamous cell cancer", start date: 2005 (unspecified if ongoing), notes: floor of mouth & tongue, full neck dissection; "squamous cell cancer" (unspecified if ongoing); "recurrence squamous cell cancer", start date: 2009 (unspecified if ongoing), notes: right side top of tongue and radiation; "radiation", start date: 2009 (unspecified if ongoing); "malnutrition", start date: 2018 (unspecified if ongoing); "Hyperbaric treatments", start date: 2014 (unspecified if ongoing), notes: 40 Dives total for extraction of some teeth; "allergies to trees, weeds" (unspecified if ongoing); "allergies to grasses, pollen" (unspecified if ongoing); "allergies to feathers, cats and dogs" (unspecified if ongoing); "allergy to steroids" (unspecified if ongoing), notes: hallucinations, mood changes and red face; "thyroid" (unspecified if ongoing); "bones" (unspecified if ongoing). Medical history also included Histamine release in the skin and in 2021, the patient had ground food diet, loss of muscle strength, base of tongue, swallow study, puree most foods. Concomitant medication(s) included: LEVOXYL taken for thyroid disorder; PEPCID [FAMOTIDINE] taken for gastrooesophageal reflux disease; VITAMIN D [VITAMIN D NOS] taken for bone disorder. Past drug history included: Vancomycin, reaction(s): "trouble breathing"; Vancomycin, reaction(s): "red man", notes: rash, itching; Doxycycline, reaction(s): "trouble breathing"; Doxycycline, reaction(s): "red man", notes: rash, itching; Cephalexin, reaction(s): "trouble breathing"; Cephalexin, reaction(s): "red man", notes: rash, itching; Ciprofloxacin, reaction(s): "trouble breathing"; Ciprofloxacin, reaction(s): "red man", notes: rash, itching; Clindamycin phosphate, reaction(s): "trouble breathing"; Clindamycin phosphate, reaction(s): "red man", notes: rash, itching; Erythromycin, reaction(s): "trouble breathing"; Erythromycin, reaction(s): "red man", notes: rash, itching; Ic cromolyn, reaction(s): "stomach pain"; Ic cromolyn, reaction(s): "trouble breathing"; Ic cromolyn, reaction(s): "hallucinations black shadows/mood changes"; Ic cromolyn, reaction(s): "hallucinations black shadows/mood changes"; Ic cromolyn, reaction(s): "vision problems"; Ic lansoprazole, reaction(s): "swelling of throat", notes: after 6 month; Ic lansoprazole, reaction(s): "trouble breathing"; Ic lansoprazole, reaction(s): "swelling of tongue", notes: after 6 month; Nitrofurantoin, reaction(s): "mood changes", notes: after 2 days; Nitrofurantoin, reaction(s): "itching", notes: after 2 days; Liquid pulmicort, reaction(s): "bronchospasms"; Asmanex twisthaer, reaction(s): "bronchospasms"; Qvar, reaction(s): "bronchospasms"; Advair hfa, reaction(s): "mood changes"; Advair hfa, reaction(s): "dizziness"; Advair hfa, reaction(s): "headache"; Advair hfa, reaction(s): "mental depress"; Flovent, reaction(s): "mood changes"; Flovent, reaction(s): "dizziness"; Flovent, reaction(s): "headache"; Flovent, reaction(s): "mental depress"; Singular, reaction(s): "vomiting"; Singular, reaction(s): "dizziness"; Symbicort, reaction(s): "dizziness"; Symbicort, reaction(s): "vomiting"; Allegra, reaction(s): "throat closing"; Allegra, reaction(s): "flushing"; Miralax, reaction(s): "rash"; Miralax, reaction(s): "itching"; Xanax, reaction(s): "mood swings"; Valium, reaction(s): "depression"; Valium, reaction(s): "mood changes". Vaccination history included: BNT162b2 (DOSE 1, lot #: EW0151), administration date: 27Jul2021, for COVID-19 Immunization, reaction(s): "heart pain/chest". The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 06Aug2021, outcome "unknown", described as "1st shot 27Jun2021, 2nd shot 06Aug2021"; ANGINA PECTORIS (medically significant), outcome "unknown", described as "heart pain/chest, 2nd shot: more pain".; Sender's Comments: Linked Report(s) : US-PFIZER INC-202400263238 same patient/reporter, different vaccine dose/event;US-PFIZER INC-PV202400131397 same patient/reporter and event, different vaccine dose;